JCV Antibody Program (STRATIFY-1)



Status:Archived
Conditions:Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:August 2012

Use our guide to learn which trials are right for you!

JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1


Study conducted to define the prevalence of Serum JC Antibody in relapsing MS patients
receiving Tysabri or being considered for such treatment.

Analytically validate the JCV antibody assay in a plasma matrix.


This study requires blood and urine collection @ enrollment and every 6 months thereafter
for up two years.


We found this trial at
10
sites
?
mi
from
Ayer, MA
Click here to add this to my saved trials
?
mi
from
Asheville, NC
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Beloit, WI
Click here to add this to my saved trials
?
mi
from
Bend, OR
Click here to add this to my saved trials
?
mi
from
Denver, CO
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Evanston, IL
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials